Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
138 articles
Clinical trial explores whether resetting gut microbiome through fecal transplants can slow Parkinson's progression and reduce symptoms.
Study tests whether fasting before or after soccer heading reduces brain injury markers and cognitive impairment in college athletes.
60-patient trial explores whether metformin, combined with standard therapy, could slow Parkinson's progression through metabolic pathways.
Neuroscientist David Eagleman reveals how neuroplasticity works and practical strategies to optimize learning and memory at any age.
Neuroscientist Dr. Read Montague reveals how dopamine functions as a learning algorithm, not just reward system.
New research reveals how targeting the brain's glymphatic drainage system might remove harmful α-synuclein buildup in Parkinson's disease.
Large study finds genetic background doesn't explain mitochondrial damage in neurodegenerative disease, pointing to complex causes.
Editorial raises concerns about influential 2009 study on Cerebrolysin's effects on brain degeneration in Alzheimer's models.
New research reveals how declining brain lymphatic drainage contributes to Alzheimer's and Parkinson's disease vulnerability.
New research reveals that 32% of early Alzheimer's patients also have alpha-synuclein protein aggregates, linked to smell loss.
Following Mediterranean or MIND diets for decades significantly reduced dementia risk and slowed cognitive aging in 130,000+ adults.
New research identifies WDR12 and HIVEP3 genes as key contributors to exceptional cognitive preservation in elderly Amish individuals.
